(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Departure of Senior Executive
Filed with SSE · Stock code 600557 · · 2 pages · Chinese
Summary by 6ix AI
Jiangsu Kanion Pharmaceutical Co. Ltd. announced the resignation of its deputy general manager, Pan Yu, due to personal reasons, effective immediately upon submission of his resignation report to the board.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/600557jiangsu-kanion-pharmaceutical-co-ltdannouncement-on-departure-of-senior-executive
Jiangsu Kanion Pharmaceutical Co. Ltd. on 6ix
Story so far
Earlier from Jiangsu Kanion Pharmaceutical
- (600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
- Semi-annual Report for 2026
- Announcement on Receipt of the Clinical Trial Approval Notice for Qihuang Zhengqi Granules
- Announcement on Initially Repurchasing Shares through Call Auction
- Announcement on Inclusion of Certain Pharmaceutical Products of the Company in the National Essential Medicines List
Later from Jiangsu Kanion Pharmaceutical
All Jiangsu Kanion Pharmaceutical news releasesFollow Jiangsu Kanion Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Kanion Pharmaceutical